Discontinued — last reported Q3 '25

Financing

Debt Issuance Costs

Year-over-year, this metric declined by 100.0%, from $3.00M to $0.00. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementCash Flow Statement
SectionFinancing
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2014
Last reportedQ3 2025

How to read this metric

Higher costs relative to issuance volume may indicate complex financing arrangements or unfavorable market conditions.

Detailed definition

This represents the cash fees and expenses paid to underwriters, legal counsel, and other parties to facilitate the issu...

Peer comparison

Typically a small percentage of total debt issued, consistent across large-cap issuers.

Metric ID: payment_of_debt_issuance_costs

Historical Data

3 years
 FY'23FY'24FY'25
Value$0.00$12.00M$0.00
YoY Change-100.0%
Range$0.00$12.00M
Avg YoY Growth-100.0%
Median YoY Growth-100.0%

Frequently Asked Questions

What is Medline, Inc. 's debt issuance costs?
Medline, Inc. (MDLN) reported debt issuance costs of $0.00 in Q4 2025.
How has Medline, Inc. 's debt issuance costs changed year-over-year?
Medline, Inc. 's debt issuance costs decreased by 100.0% year-over-year, from $3.00M to $0.00.
What does debt issuance costs mean?
Cash paid for fees related to issuing new debt.